J9315 — Injection, romidepsin, 1 mg
J9315 is a HCPCS Level II code for injection, romidepsin, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2021 and is not valid on new claims.
This code has been terminated
CMS terminated J9315 on September 30, 2021. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9315
- Long descriptor
- Injection, romidepsin, 1 mg
- Short descriptor
- Romidepsin injection
- Added
- January 1, 2011
- Terminated
- September 30, 2021
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9315
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9315 is not quite right, the correct code is very often within a few positions of it.
- J9307Injection, pralatrexate, 1 mg
- J9308Injection, ramucirumab, 5 mg
- J9309Injection, polatuzumab vedotin-piiq, 1 mg
- J9310Injection, rituximab, 100 mgterminated
- J9311Injection, rituximab 10 mg and hyaluronidase
- J9312Injection, rituximab, 10 mg
- J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319Injection, romidepsin, lyophilized, 0.1 mg
- J9320Injection, streptozocin, 1 gram
- J9321Injection, epcoritamab-bysp, 0.16 mg
- J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323Injection, pemetrexed ditromethamine, 10 mg
Questions about J9315
What is HCPCS code J9315?
J9315 is a HCPCS Level II code for injection, romidepsin, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9315?
The CMS HCPCS file marks J9315 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J9315 still valid?
No. J9315 was terminated on September 30, 2021 and should not be used on new claims.